{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:48:01Z","timestamp":1724978881590},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.hfc.2024.06.009","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:49:22Z","timestamp":1724964562000},"page":"437-444","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies"],"prefix":"10.1016","volume":"20","author":[{"given":"Michael J.","family":"Pienta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hfc.2024.06.009_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1540-8191.2011.01274.x","article-title":"Respective prevalence of the different carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development","volume":"26","author":"de Marchena","year":"2011","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.hfc.2024.06.009_bib2","article-title":"Percutaneous mitral valve repair in patients with secondary mitral regurgitation and advanced heart failure","volume":"2020","author":"Scotti","year":"2020","journal-title":"Mini-invasive Surgery"},{"issue":"12","key":"10.1016\/j.hfc.2024.06.009_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","article-title":"Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations","volume":"65","author":"Asgar","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.06.009_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehx402","article-title":"Refining the prognostic impact of functional mitral regurgitation in chronic heart failure","volume":"39","author":"Goliasch","year":"2018","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hfc.2024.06.009_bib5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2017.2976","article-title":"Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis","volume":"2","author":"Sannino","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"13","key":"10.1016\/j.hfc.2024.06.009_bib6","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","article-title":"Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment","volume":"103","author":"Grigioni","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2024.06.009_bib7","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.hfc.2024.06.009_bib8","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2024.06.009_bib9","doi-asserted-by":"crossref","first-page":"e009689","DOI":"10.1161\/CIRCHEARTFAILURE.122.009689","article-title":"Medical therapy for functional mitral regurgitation","volume":"15","author":"Milwidsky","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.hfc.2024.06.009_bib10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","article-title":"Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation","volume":"139","author":"Kang","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2024.06.009_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jchf.2017.06.015","article-title":"Evolution of functional mitral regurgitation and prognosis in medically managed heart failure patients with reduced ejection fraction","volume":"5","author":"Nasser","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2024.06.009_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0041-1345(01)02717-8","article-title":"Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction","volume":"34","author":"Comin-Colet","year":"2002","journal-title":"Transplant Proc"},{"issue":"10254","key":"10.1016\/j.hfc.2024.06.009_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hfc.2024.06.009_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.120.052186","article-title":"Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)","volume":"143","author":"Lee","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2024.06.009_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jtcvs.2008.11.010","article-title":"POINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial","volume":"138","author":"Fattouch","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"21","key":"10.1016\/j.hfc.2024.06.009_bib16","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.112.143818","article-title":"Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial","volume":"126","author":"Chan","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.009_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0145-4145(08)01037-X","article-title":"Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation","volume":"2008","author":"Cheitlin","year":"2008","journal-title":"Year Bk Cardiol"},{"issue":"23","key":"10.1016\/j.hfc.2024.06.009_bib18","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2021.07.058","article-title":"Transcatheter mitral valve therapy in the United States: a report from the STS-ACC TVT registry","volume":"78","author":"Mack","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.hfc.2024.06.009_bib19","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.hfc.2024.06.009_bib20","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.hfc.2024.06.009_bib21","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jcin.2020.06.058","article-title":"NYHA functional classification and outcomes after transcatheter mitral valve repair in heart failure: the COAPT trial","volume":"13","author":"Giustino","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.hfc.2024.06.009_bib22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2020.12.047","article-title":"3-year outcomes of transcatheter mitral valve repair in patients with heart failure","volume":"77","author":"Mack","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2024.06.009_bib23","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/ejhf.1616","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years","volume":"21","author":"Iung","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"10.1016\/j.hfc.2024.06.009_bib24","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jacc.2019.02.010","article-title":"Health status after transcatheter mitral-valve repair in heart failure and secondary mitral regurgitation: COAPT trial","volume":"73","author":"Arnold","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.hfc.2024.06.009_bib25","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.jacc.2021.10.011","article-title":"Outcomes stratified by adapted inclusion criteria after mitral edge-to-edge repair","volume":"78","author":"Koell","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.06.009_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcin.2020.09.050","article-title":"COAPT-like profile predicts long-term outcomes in patients with secondary mitral regurgitation undergoing MitraClip implantation","volume":"14","author":"Adamo","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hfc.2024.06.009_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2020.05.061","article-title":"Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair","volume":"316","author":"Iliadis","year":"2020","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2024.06.009_bib28","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/ejhf.1774","article-title":"The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitation","volume":"22","author":"Reichart","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.hfc.2024.06.009_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","article-title":"Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials","volume":"12","author":"Grayburn","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2024.06.009_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamacardio.2019.5971","article-title":"New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation","volume":"5","author":"Packer","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2024.06.009_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamacardio.2020.7200","article-title":"Association of effective regurgitation orifice area to left ventricular end-diastolic volume ratio with transcatheter mitral valve repair outcomes: a secondary analysis of the COAPT trial","volume":"6","author":"Lindenfeld","year":"2021","journal-title":"JAMA cardiology"},{"issue":"4","key":"10.1016\/j.hfc.2024.06.009_bib32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jcmg.2020.07.021","article-title":"Impact of mitral regurgitation severity and left ventricular remodeling on outcome after mitraclip implantation: results from the mitra-fr trial","volume":"14","author":"Messika-Zeitoun","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2024.06.009_bib33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcmg.2020.05.042","article-title":"Impact of proportionality of secondary mitral regurgitation on outcome after transcatheter mitral valve repair","volume":"14","author":"Orban","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.06.009_bib34","article-title":"Disproportionate secondary mitral regurgitation: myths, misconceptions and clinical implications","author":"Grayburn","year":"2020","journal-title":"Heart"},{"issue":"23","key":"10.1016\/j.hfc.2024.06.009_bib35","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/CIRCULATIONAHA.119.043275","article-title":"Cost-effectiveness of transcatheter mitral valve repair versus medical therapy in patients with heart failure and secondary mitral regurgitation: results from the COAPT trial","volume":"140","author":"Baron","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2024.06.009_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2015.10.046","article-title":"Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement","volume":"67","author":"Reynolds","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2024.06.009_bib37","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.healun.2020.09.005","article-title":"MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry","volume":"39","author":"Godino","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.hfc.2024.06.009_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rec.2022.05.006","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the european society of cardiology (ESC) and the European association for Cardio-Thoracic surgery (EACTS)","volume":"75","author":"Vahanian","year":"2022","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"13","key":"10.1016\/j.hfc.2024.06.009_bib39","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/eurheartj\/ehab086","volume":"42","author":"Coats","year":"2021","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.hfc.2024.06.009_bib40","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.jcin.2022.08.005","article-title":"Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score","volume":"15","author":"Shah","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.hfc.2024.06.009_bib41","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jacc.2021.11.041","article-title":"A\u00a0score to assess mortality after percutaneous mitral valve repair","volume":"79","author":"Raposeiras-Roubin","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.hfc.2024.06.009_bib42","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jcin.2021.06.039","article-title":"Machine learning identifies clinical parameters to predict mortality in patients undergoing transcatheter mitral valve repair","volume":"14","author":"Zweck","year":"2021","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T21:49:22Z","timestamp":1724968162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1551713624000540"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.06.009","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}